Status:
COMPLETED
The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Deficiency
Lead Sponsor:
Neon Hospital
Conditions:
Androgen Deficiency
Ocular Surface Disease
Eligibility:
MALE
18-75 years
Phase:
NA
Brief Summary
Objective: To evaluate tear osmolarity and ocular surface findings in men with androgen deficiency (AD) and assess changes after androgen replacement therapy (ART). Design: A prospective intervention...
Eligibility Criteria
Inclusion
- Androgen deficiency
Exclusion
- having any ocular disease, history of surgery, drop use
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2025
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT07168265
Start Date
January 1 2020
End Date
June 15 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuz Mayıs University
Samsun, Atakum, Turkey (Türkiye), 55139